Literature DB >> 5671706

[Overexcitability of the gamma-motor neurons in "stiff-man" syndrome].

H G Mertens, K Ricker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5671706     DOI： 10.1007/bf01725298

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  26 in total

1.  "STIFF-MAN" SYNDROME: A REVIEW OF THE LITERATURE, REPORT OF THREE ADDITIONAL CASES AND DISCUSSION OF PATHOPHYSIOLOGY AND THERAPY.

Authors:  R A OLAFSON; D W MULDER; F M HOWARD
Journal:  Mayo Clin Proc       Date:  1964-02       Impact factor: 7.616

2.  Dysphagia--an unusual presenting symptom of the "stiff-man syndrome".

Authors:  R SIEGLER
Journal:  Arch Pathol       Date:  1960-10

3.  The stiff-man syndrome: report of a case.

Authors:  F S STUART; M HENRY; H L HOLLEY
Journal:  Arthritis Rheum       Date:  1960-06

4.  "Stiff-man" syndrome.

Authors:  R E WHALEN; J J COMBS; W P DEISS
Journal:  Am J Med       Date:  1959-10       Impact factor: 4.965

5.  The relative sensitivity of muscle nerve fibres to procaine.

Authors:  P B MATTHEWS; G RUSHWORTH
Journal:  J Physiol       Date:  1957-02-15       Impact factor: 5.182

6.  Activation of muscle spindles by succinylcholine and decamethonium, the effects of curare.

Authors:  R GRANIT; S SKOGLUND; S THESLEFF
Journal:  Acta Physiol Scand       Date:  1953

7.  CHRONIC GENERALIZED FIBROMYOSITIS.

Authors:  A M Ornsteen
Journal:  Ann Surg       Date:  1935-01       Impact factor: 12.969

8.  A SYNDROME OF CONTINUOUS MUSCLE-FIBRE ACTIVITY.

Authors:  H Isaacs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1961-11       Impact factor: 10.154

9.  [Facial spasm, a parabiotic phenomenon; electrophysiological studies on the pathogenetic mechanism of facial spasm].

Authors:  E ESSLEN
Journal:  Dtsch Z Nervenheilkd       Date:  1957

10.  Stiff-man syndrome. Two patients treated with diazepam.

Authors:  L Cohen
Journal:  JAMA       Date:  1966-01-17       Impact factor: 56.272
View more
  10 in total

1.  [A clinical and neurophysiological study of an uncommon myoclonic syndrome].

Authors:  K Meier-Ewert; E Schenck; W Kuhlo
Journal:  Dtsch Z Nervenheilkd       Date:  1969-10

2.  [Unusual types of tetanus. Clinical and electromyographic study].

Authors:  K Ricker; K Eyrich; R Zwirner
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1971

3.  Stiff-man syndrome with central and peripheral nervous manifestations.

Authors:  H Nyland; S I Mellgren; A G Frövig
Journal:  J Neurol       Date:  1978-12-07       Impact factor: 4.849

4.  Isaacs syndrome: a syndrome of continuous muscle-fiber activity.

Authors:  N A Il'ina; V B Biryukov; M V Luk'yanov; N F Polyakova
Journal:  Neurosci Behav Physiol       Date:  1981 Jul-Aug

5.  Stiff-man syndrome associated with nocturnal myoclonus and epilepsy.

Authors:  P Martinelli; P Pazzaglia; P Montagna; G Coccagna; N Rizzuto; S Simonati; E Lugaresi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

6.  The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine.

Authors:  H M Meinck; K Ricker; B Conrad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

7.  Stiff man syndrome: clinical and laboratory findings in eight patients.

Authors:  H M Meinck; K Ricker; P J Hülser; E Schmid; J Peiffer; M Solimena
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

8.  Neuropharmacological investigations in the stiff-man syndrome.

Authors:  H M Meinck; B Conrad
Journal:  J Neurol       Date:  1986-11       Impact factor: 4.849

9.  [The stiff-man syndrome. A case report with regard to clinical, electromyographical and pharmacological signs (author's transl)].

Authors:  M Stöhr; R Heckl
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-02-23

10.  Electrophysiological studies on the "stiff-man" syndrome.

Authors:  B Mamoli; W D Heiss; E Maida; I Podreka
Journal:  J Neurol       Date:  1977-12-13       Impact factor: 4.849
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.